Caution should be exercised when patients previously given Simulect are re-exposed to a subsequent course of therapy with this medicinal product.
Ettevaatus on vajalik ka nende juba varasemalt Simulect- ravi saanud patsientide korral, kellele määratakse järgnev ravi selle ravimiga.